NASDAQ:BSGM

BioSig Technologies (BSGM) Stock Forecast, Price & News

$0.50

-0.03 (-5.61%)

(As of 09/27/2023 ET)

Compare

Today's Range: $0.50
▼
$0.56
50-Day Range: $0.41
▼
$1.39
52-Week Range: $0.25
▼
$1.65

Volume: 110,562 shs
Average Volume: 490,652 shs
Market Capitalization: $37.79 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.50

BioSig Technologies MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 594.0% Upside
$3.50 Price Target
Short Interest: Healthy
3.32% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.29
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.42) to ($0.24) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Medical Sector

523rd out of 976 stocks

Electromedical Equipment Industry

12th out of 22 stocks

3.5

Analyst's Opinion

Consensus Rating
BioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.50, BioSig Technologies has a forecasted upside of 594.0% from its current price of $0.50.
Amount of Analyst Coverage
BioSig Technologies has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
3.32% of the outstanding shares of BioSig Technologies have been sold short.
Short Interest Ratio / Days to Cover
BioSig Technologies has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in BioSig Technologies has recently decreased by 2.73%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
BioSig Technologies does not currently pay a dividend.
Dividend Growth
BioSig Technologies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BSGM.

2.4

News and Social Media Coverage

News Sentiment
BioSig Technologies has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for BioSig Technologies this week, compared to 0 articles on an average week.
Search Interest
Only 2 people have searched for BSGM on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
MarketBeat Follows
8 people have added BioSig Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 700% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BioSig Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
11.88% of the stock of BioSig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 7.16% of the stock of BioSig Technologies is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for BioSig Technologies are expected to grow in the coming year, from ($0.42) to ($0.24) per share.
Price to Book Value per Share Ratio
BioSig Technologies has a P/B Ratio of 50.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About BioSig Technologies (NASDAQ:BSGM) Stock

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BSGM Price History

30 days | 90 days | 365 days | Advanced Chart

BSGM Stock News Headlines

September 19, 2023 | americanbankingnews.com

Comparing Integer (NYSE:ITGR) & BioSig Technologies (NASDAQ:BSGM)

September 6, 2023 | benzinga.com

BioSig – Medical Device Maker Is Revolutionizing How Arrhythmias Are Treated

September 28, 2023 | UNKNOWN (Ad)

The Bio-Tech Stock That Needs Your Attention!

There a Few Opportunities Like This Stock! Sign Up Today And Get Our NExt Bio-Tech Alert!

August 25, 2023 | finance.yahoo.com

BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model

August 24, 2023 | finance.yahoo.com

BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals

August 16, 2023 | finance.yahoo.com

BioSig Technologies Second Quarter 2023 Earnings: US$0.16 loss per share (vs US$0.15 loss in 2Q 2022)

July 25, 2023 | finance.yahoo.com

BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications

July 21, 2023 | finance.yahoo.com

NVIDIA Inception Chooses BioSig AI For Innovation In Healthcare AI, An Industry That Is Projected To Reach $272.9 Billion By 2030

September 28, 2023 | Chaikin Analytics (Ad)

His system isolated NVIDIA - Here's His Next Buy.

Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.

July 20, 2023 | theglobeandmail.com

Healthcare Shares Bid Up Following Major Premarket Announcement

July 20, 2023 | markets.businessinsider.com

Why Is BioSig Technologies (BSGM) Stock Up 19% Today?

July 20, 2023 | finance.yahoo.com

BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals

June 29, 2023 | finance.yahoo.com

BioSig Joins Webull Corporate Connect

June 27, 2023 | finance.yahoo.com

BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare

May 24, 2023 | benzinga.com

New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market

May 19, 2023 | finance.yahoo.com

New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias

May 16, 2023 | investing.com

Biosig Tech (BSGM) Earnings Dates & Reports

March 27, 2023 | finance.yahoo.com

BioSig Announces New Advisory Board Member Edwin Wang

March 24, 2023 | finance.yahoo.com

BioSig Announces New Advisory Board Member Lorraine Spurge

March 13, 2023 | finance.yahoo.com

BioSig Confirms No Exposure to Silicon Valley Bank

February 22, 2023 | finance.yahoo.com

BioSig Regains Compliance With All Nasdaq Listing Standards

February 22, 2023 | finance.yahoo.com

BioSig Regains Compliance With All Nasdaq Listing Standards

February 17, 2023 | finance.yahoo.com

BioSig Awarded US Patent Claims for its Universal Notch Filter Technology

February 7, 2023 | msn.com

BioSig names Steve Buhaly CFO replacing Chaussy

February 7, 2023 | marketwatch.com

BioSig Names Buhaly as Finance Chief as Chaussy to Retire >BSGM

February 7, 2023 | finance.yahoo.com

BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy

January 19, 2023 | finance.yahoo.com

BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments

See More Headlines

Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

BSGM Company Calendar

Last Earnings: 3/31/2022
Today: 9/28/2023
Next Earnings (Estimated): 10/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electromedical equipment
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:BSGM
CUSIP: N/A
CIK: 1530766
Web: www.biosig.com
Phone: (230) 409-5444
Fax: N/A
Employees: 47
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $3.50
High Stock Price Forecast: $5.00
Low Stock Price Forecast: $2.00
Forecasted Upside/Downside: +594.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-27,050,000.00
Net Margins: -9,336.04%
Pretax Margin: -11,633.82%
Return on Equity: -2,915.50%
Return on Assets: -693.01%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.60
Quick Ratio: 0.54

Sales & Book Value

Annual Sales: $290,000.00
Price / Sales: 130.30
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.01 per share
Price / Book: 50.43

Miscellaneous

Outstanding Shares: 74,930,000
Free Float: 66,026,000
Market Cap: $37.79 million
Optionable: Not Optionable
Beta: 1.37

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Kenneth L. Londoner M.B.A. (Age 55)
MBA, Founder, CEO & Exec. Chairman
Comp: $1.17M

Mr. John Sieckhaus (Age 55)
Chief Operating Officer
Comp: $282.52k

Mr. Michael Graydon Fleming Jr. (Age 49)
Chief Commercial Officer
Comp: $400k

Mr. Steven J. Buhaly (Age 66)
Chief Financial Officer

Dr. Budimir S. Drakulic Ph.D. (Age 73)
Chief Scientist

Mr. Andrew Gornell Ballou
VP of Investor Relations

Ms. Brenda Castrodad
VP of HR

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BSGM Stock - Frequently Asked Questions

Should I buy or sell BioSig Technologies stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BSGM shares.
View BSGM analyst ratings or view top-rated stocks.
What is BioSig Technologies' stock price forecast for 2023?: 2 Wall Street research analysts have issued 1-year price targets for BioSig Technologies' stock. Their BSGM share price forecasts range from $2.00 to $5.00. On average, they predict the company's share price to reach $3.50 in the next twelve months. This suggests a possible upside of 594.0% from the stock's current price.
View analysts price targets for BSGM or view top-rated stocks among Wall Street analysts.
How have BSGM shares performed in 2023?: BioSig Technologies' stock was trading at $0.42 at the beginning of 2023. Since then, BSGM stock has increased by 20.1% and is now trading at $0.5043.
View the best growth stocks for 2023 here.
When is BioSig Technologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, October 2nd 2023.
View our BSGM earnings forecast.
How were BioSig Technologies' earnings last quarter?: BioSig Technologies, Inc. (NASDAQ:BSGM) posted its earnings results on Thursday, March, 31st. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.22) by $0.02. BioSig Technologies had a negative net margin of 9,336.04% and a negative trailing twelve-month return on equity of 2,915.50%.
What other stocks do shareholders of BioSig Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

What is BioSig Technologies' stock symbol?: BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM."
Who are BioSig Technologies' major shareholders?: BioSig Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Advisor Resource Council (1.28%), BlackRock Inc. (0.84%), Geode Capital Management LLC (0.80%), Northern Trust Corp (0.16%), PFG Investments LLC (0.11%) and Sequoia Financial Advisors LLC (0.10%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy.
View institutional ownership trends.
How do I buy shares of BioSig Technologies?: Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is BioSig Technologies' stock price today?: One share of BSGM stock can currently be purchased for approximately $0.50.
How much money does BioSig Technologies make?: BioSig Technologies (NASDAQ:BSGM) has a market capitalization of $37.79 million and generates $290,000.00 in revenue each year.
How can I contact BioSig Technologies?: BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The official website for the company is www.biosig.com. The company can be reached via phone at (230) 409-5444 or via email at info@biosigtech.com.

This page (NASDAQ:BSGM) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial